Nicola La Monica,
Senior Director, Scientific Innovation, Infectious Diseases and Vaccines
From 2009 to 2012, Nicola was at Idera Pharmaceuticals, where he was Vice President of biology. From 1991 to 2009, he was the Director of Antiviral Research at the Istituto di Ricerche di Biologia Molecolare (IRBM), Rome, Italy, a research site of Merck Research Laboratories. Prior to that, he held the positions of Director of Oncology and Director of Cancer Immunology and Genomics.
During his career, Nicola has led drug discovery efforts for the treatment of Hepatitis C virus infections and oncology, as well as development programs for cancer immunotherapy. Nicola earned his BA degree in Biology from the University of Rochester in 1982. His graduate studies were completed at Columbia University, where he earned a PhD in Microbiology in 1988.